S-Space

Browse

Title

전체 가 나 다 라 마 바 사 아 자 차 카 타 파 하

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Sort by
In order
Results/Page
Authors/record

Showing results 4,541 to 4,560 of 7,897

Issue Date	Title / Author(s) / Citation	File
1990-03	Pharmacokinetics of Amitriptyline Demethylation;A Crossover Study with Single Doses of Amitriptyline and Nortriptyline Jang, In-Jin; Shin, Jae-Gook; Shin, Sang-Goo; Park, Chan-Woong; Kim, Jae-Jin; Woo, Jong-In; Cha, In-Jun Seoul J Med, Vol.31 No.1, pp. 11-18	view file
2019-09	Pharmacokinetics of pertuzumab administered concurrently with trastuzumab in Chinese patients with HER2-positive early breast cancer Luo, Yang; Li, Wei; Jiang, Zefei; Zhang, Qingyuan; Wang, Liwei; Mao, Yixiang; Tjan-Heijnen, Vivianne C. G.; Im, Seock-Ah; McConnell, Robin; Bejarano, Sara; Fumagalli, Debora; Bines, Jose; Wang, Bei; Garg, Amit; Kirschbrown, Whitney P.; Xu, Binghe Anti-Cancer Drugs, Vol.30 No.8, pp.866-872	DOI
2021-11	Pharmacokinetics, Safety, and Efficacy of Trastuzumab Deruxtecan with Concomitant Ritonavir or Itraconazole in Patients with HER2-Expressing Advanced Solid Tumors Takahashi, Shunji; Karayama, Masato; Takahashi, Masato; Watanabe, Junichiro; Minami, Hironobu; Yamamoto, Noboru; Kinoshita, Ichiro; Lin, Chia-Chi; Im, Young-Hyuck; Achiwa, Issei; Kamiyama, Emi; Okuda, Yasuyuki; Lee, Caleb; Bang, Yung-Jue Clinical Cancer Research, Vol.27 No.21, pp.5771-5780	DOI
2021-03	Pharmacological interventions for pulmonary involvement in rheumatic diseases Kang, Eun Ha; Song, Yeong Wook Pharmaceuticals, Vol.14 No.3, p. 251	DOI
2018-07	Phase 1 studies of poziotinib, an irreversible pan-her tyrosine kinase inhibitor in patients with advanced solid tumors Kim, Tae Min; Lee, Keun-Wook; Oh, Do-Youn; Lee, Jong-Seok; Im, Seock-Ah; Kim, Dong-Wan; Han, Sae-Won; Kim, Yu Jung; Kim, Tae-You; Kim, Jee Hyun; Han, Hyesun; Kim, Woo Ho; Bang, Yung-Jue Cancer Research and Treatment, Vol.50 No.3, pp.835-842	DOI
2020-02	Phase 1 study of capmatinib in MET-positive solid tumor patients: Dose escalation and expansion of selected cohorts Bang, Yung-Jue; Su, Wu-Chou; Schuler, Martin; Nam, Do-Hyun; Lim, Wan Teck; Bauer, Todd M.; Azaro, Analia; Poon, Ronnie Tung Ping; Hong, David; Lin, Chia-Chi; Akimov, Mikhail; Ghebremariam, Samson; Zhao, Sylvia; Giovannini, Monica; Ma, Brigette Cancer Science, Vol.111 No.2, pp.536-547	DOI
2015-08	Phase 2 study of dovitinib in patients with metastatic or unresectable adenoid cystic carcinoma Keam, Bhumsuk; Kim, Sung-Bae; Shin, Seong Hoon; Cho, Byoung Chul; Lee, Keun-Wook; Kim, Min Kyoung; Yun, Hwan-Jung; Lee, Se-Hoon; Yoon, Dok Hyun; Bang, Yung-Jue Cancer, Vol.121 No.15, pp.2612-2617	DOI
2012-12	Phase 2 Study of Everolimus Monotherapy in Patients With Nonfunctioning Neuroendocrine Tumors or Pheochromocytomas/Paragangliomas Oh, Do-Youn; Kim, Tae-Won; Park, Young Suk; Shin, Sang Joon; Shin, Seong Hoon; Song, Eun-Kee; Lee, Hyo Jin; Lee, Kewn-Wook; Bang, Yung-Jue Cancer, Vol.118 No.24, pp.6162-6170	DOI
2018-04	Phase 2 study of the HSP-90 inhibitor AUY922 in previously treated and molecularly defined patients with advanced non-small cell lung cancer Felip, Enriqueta; Barlesi, Fabrice; Besse, Benjamin; Chu, Quincy; Gandhi, Leena; Kim, Sang-We; Carcereny, Enric; Sequist, Lecia V.; Brunsvig, Paal; Chouaid, Christos; Smit, Egbert F.; Groen, Harry J. M.; Kim, Dong-Wan; Park, Keunchil; Avsar, Emin; Szpakowski, Sebastian; Akimov, Mikhail; Garon, Edward B. Journal of Thoracic Oncology, Vol.13 No.4, pp.576-584	DOI
2004-06	Phase I and pharmacokinetic study of Genexol-PM, a cremophor-free, polymeric micelle-formulated paclitaxel, in patients with advanced malignancies Kim, Tae You; Kim, Dong-Wan; Chung, Jae-Yong; Shin, Sang Goo; Kim, Sung-Chul; Heo, Dae Seog; Kim, Noe Kyeong; Bang, Yung-Jue Clinical Cancer Research, Vol.10 No.11, pp.3708-3716	DOI
2022-09	Phase I Clinical Trial of Prostate-Specific Membrane Antigen-Targeting 68Ga-NGUL PET/CT in Healthy Volunteers and Patients with Prostate Cancer Suh, Minseok; Ryoo, Hyun Gee; Kang, Keon Wook; Jeong, Jae Min; Jeong, Chang Wook; Kwak, Cheol; Cheon, Gi Jeong Korean Journal of Radiology, Vol.23 No.9, pp.911-920	DOI
2017-10	Phase I dose-escalation study of the c-Met tyrosine kinase inhibitor SAR125844 in Asian patients with advanced solid tumors, including patients with MET-amplified gastric cancer Shitara, Kohei; Kim, Tae Min; Yokota, Tomoya; Goto, Masahiro; Satoh, Taroh; Ahn, Jin-Hee; Kim, Hyo Song; Assadourian, Sylvie; Gomez, Corinne; Harnois, Marzia; Hamauchi, Satoshi; Kudo, Toshihiro; Doi, Toshihido; Bang, Yung-Jue Oncotarget, Vol.8 No.45, pp.79546-79555	DOI
2020-07	Phase I Escalation and Expansion Study of Bemarituzumab (FPA144) in Patients With Advanced Solid Tumors and FGFR2b-Selected Gastroesophageal Adenocarcinoma Catenacci, Daniel V. T.; Rasco, Drew; Lee, Jeeyun; Rha, Sun Young; Lee, Keun-Wook; Bang, Yung Jue; Bendell, Johanna; Enzinger, Peter; Marina, Neyssa; Xiang, Hong; Deng, Wei; Powers, Janine; Wainberg, Zev A. Journal of Clinical Oncology, Vol.38 No.21, pp.2418-2426	DOI
2018-02	Phase I pharmacokinetic study of nivolumab in Korean patients with advanced solid tumors Lee, Keun-Wook; Lee, Dae Ho; Kang, Jin Hyoung; Park, Joon Oh; Kim, Se Hyun; Hong, Yong Sang; Kim, Seung Tae; Oh, Do-Youn; Bang, Yung-Jue Oncologist, Vol.23 No.2, pp.155-e17	DOI
2015-10	Phase I Study of Axitinib in Combination with Cisplatin and Capecitabine in Patients with Previously Untreated Advanced Gastric Cancer Oh, Do-Youn; Doi, Toshihiko; Shirao, Kuniaki; Lee, Keun-Wook; Park, Sook Ryun; Chen, Ying; Yang, Liqiang; Valota, Olga; Bang, Yung-Jue Cancer Research and Treatment, Vol.47 No.4, pp.687-696	DOI
2016-01	Phase I study of CKD-516, a novel vascular disrupting agent, in patients with advanced solid tumors Oh, Do-Youn; Kim, Tae-Min; Han, Sae-Won; Shin, Dong-Yeop; Lee, Yun Gyoo; Lee, Keun-Wook; Kim, Jee Hyun; Kim, Tae-You; Jang, In-Jin; Lee, Jong-Seok; Bang, Yung-Jue Cancer Research and Treatment, Vol.48 No.1, pp.28-36	DOI
2021-12	Phase I study of daily and weekly regimens of the orally administered MDM2 antagonist idasanutlin in patients with advanced tumors Italiano, Antoine; Miller, Wilson H., Jr.; Blay, Jean-Yves; Gietema, Jourik A.; Bang, Yung-Jue; Mileshkin, Linda R.; Hirte, Hal W.; Higgins, Brian; Blotner, Steven; Nichols, Gwen L.; Chen, Lin Chi; Petry, Claire; Yang, Qi Joy; Schmitt, Christophe; Jamois, Candice; Siu, Lillian L. Investigational New Drugs, Vol.39 No.6, pp.1587-1597	DOI
2015-10	Phase I Study of OPB-31121, an Oral STAT3 Inhibitor, in Patients with Advanced Solid Tumors Oh, Do-Youn; Lee, Se-Hoon; Han, Sae-Won; Kim, Mi-Jung; Kim, Tae-Min; Kim, Tae-You; Heo, Dae Seog; Yuasa, Miyuki; Yanagihara, Yasuo; Bang, Yung-Jue Cancer Research and Treatment, Vol.47 No.4, pp.607-615	DOI
2016-03	Phase I study of random healthy donor-derived allogeneic natural killer cell therapy in patients with malignant lymphoma or advanced solid tumors Yang, Yaewon; Lim, Okjae; Kim, Tae Min; Ahn, Yong-Oon; Choi, Hana; Chung, Hyejin; Min, Bokyung; Her, Jung Hyun; Cho, Sung Yoo; Keam, Bhumsuk; Lee, Se-Hoon; Kim, Dong-Wan; Hwang, Yu Kyeong; Heo, Dae Seog Cancer immunology research, Vol.4 No.3, pp.215-224	DOI
2013-12	Phase I study of sunitinib plus capecitabine/cisplatin or capecitabine/oxaliplatin in advanced gastric cancer Lee, K. -W.; Park, S. R.; Oh, D. -Y.; Park, Y. -I.; Khosravan, R.; Lin, X.; Lee, S. -Y.; Roh, E. -J.; Valota, O.; Lechuga, M. J.; Bang, Y. -J. Investigational New Drugs, Vol.31 No.6, pp.1547-1558	DOI

1 225 226 227 228 229 230 231 395